APL Bioengineering (Sep 2023)

Human gut epithelium features recapitulated in MINERVA 2.0 millifluidic organ-on-a-chip device

  • Francesca Donnaloja,
  • Luca Izzo,
  • Marzia Campanile,
  • Simone Perottoni,
  • Lucia Boeri,
  • Francesca Fanizza,
  • Lorenzo Sardelli,
  • Emanuela Jacchetti,
  • Manuela T. Raimondi,
  • Laura Di Rito,
  • Ilaria Craparotta,
  • Marco Bolis,
  • Carmen Giordano,
  • Diego Albani

DOI
https://doi.org/10.1063/5.0144862
Journal volume & issue
Vol. 7, no. 3
pp. 036117 – 036117-14

Abstract

Read online

We developed an innovative millifluidic organ-on-a-chip device, named MINERVA 2.0, that is optically accessible and suitable to serial connection. In the present work, we evaluated MINERVA 2.0 as millifluidic gut epithelium-on-a-chip by using computational modeling and biological assessment. We also tested MINERVA 2.0 in a serially connected configuration prodromal to address the complexity of multiorgan interaction. Once cultured under perfusion in our device, human gut immortalized Caco-2 epithelial cells were able to survive at least up to 7 days and form a three-dimensional layer with detectable tight junctions (occludin and zonulin-1 positive). Functional layer development was supported by measurable trans-epithelial resistance and FITC-dextran permeability regulation, together with mucin-2 expression. The dynamic culturing led to a specific transcriptomic profile, assessed by RNASeq, with a total of 524 dysregulated transcripts (191 upregulated and 333 downregulated) between static and dynamic condition. Overall, the collected results suggest that our gut-on-a-chip millifluidic model displays key gut epithelium features and, thanks to its modular design, may be the basis to build a customizable multiorgan-on-a-chip platform.